Real Life Sciences supplies Orally Administered Alkylating Temozolomide Capsules. Real Life Sciences is a research-driven, biotechnology-led, life sciences organization. Orally Administered Alkylating Temozolomide Capsules is a prodrug of the imidazotetrazine class, rapidly and completely absorbed and, at physiological pH, spontaneously hydrolyzed into the active metabolite. Orally Administered Alkylating Temozolomide Capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment. These capsules are indicated for the treatment of adult patients with refractory anaplastic astrocytoma, i.E. Patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.